Article
The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
7 Jul 2021
Abstract excerpt
Diffuse large B-cell lymphoma (DLBCL) is the most frequent lymphoid malignancy affecting adults. The NF-κB transcription factor family is activated by 2 main pathways, the canonical and the alternative NF-κB activation pathway, with different functions. The alternative NF-κB pathway leads to activation of the transcriptionally active RelB NF-κB subunit. Alternative NF-κB activation status and its role in DLBCL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
